Dr. Harris Berman, HMO pioneer and former Tufts University School of Medicine dean, dies at 83 – The Boston Globe

Dr. Berman, who finished his career as what he cheerfully described as the oldest medical school dean in the United States, died in Tufts Medical Center on Oct. 30 of congestive heart failure. He was 83 and lived in Brookline.

A cofounder in 1971 of the Matthew Thornton Health Plan not-for-profit HMO in New Hampshire, Dr. Berman became chief executive of Tufts Health Plan in 1986, guiding it while its membership grew from 60,000 to 1 million.

Then at 65, he joined the Tufts University School of Medicine faculty, initially chairing the department of public health and community medicine, then serving as dean of public health and professional degree programs.

Dr. Berman was named interim dean of the medical school in 2009. When the interim title was dropped two years later, he became at 73 the oldest medical school dean in the nation, as far as anyone could tell. He retired in 2019.

He came in and did something thats, unfortunately, quite rare in a university. He spent a lot of time listening to other people, said Lawrence Bacow, who was president of Tufts when Dr. Berman was interim dean, and is now president of Harvard University.

Harris never felt the need to be the smartest person in the room, although he often was, Bacow said at Dr. Bermans funeral service. And whenever he spoke, people realized that he was the wisest. And in an academic setting, wisdom is often a much scarcer resource than intellect.

Part of Dr. Bermans wisdom was rooted in his Peace Corps experience, and that illuminating conversation with a young bureaucrat.

The revelation that another country spent its limited financial resources for health care on prevention was a whole new way of thinking for me, he said in a 2011 interview with a Tufts publication when he was named dean of the School of Medicine.

Ive never forgotten that guy, Dr. Berman said. He certainly affected my thinking and my future. He was absolutely right. Even in this country, where we have lots of money and lots of resources, we still dont have enough, and we should spend more than we do on public health and prevention. India got me interested in population medicine, in the whole question of how you prevent illness.

And that, he added, eventually led me to get involved with starting HMOs. How do you take care of a population? How do you take the budget you have and do the most that you can for people in your care? How do you keep them healthy, and prevent illness? That experience in India was formative for me.

With Dr. James Squires, he launched Matthew Thornton in New Hampshire, where they both were from, and the HMO grew to about 50,000 members.

Then he switched to leading Tufts Health Plan, taking a very businesslike path for someone who had trained as a physician.

My dad was a businessman, and I had heard business talk at the dinner table all my life, Dr. Berman said. Business came naturally to me.

The older of two siblings, Harris Alan Berman was born in Concord, N.H., on May 30, 1938.

His father, Frederick Berman, ran a wholesale plumbing and heating supply business. His mother, Marion Rubin Berman, who was known as Mitzi, was a pianist. A New England Conservatory graduate at age 19, she performed, accompanied, and taught lessons and encouraged her sons lifelong love of and involvement with music.

At Concord High School, the student newspaper dubbed him Busy Bee Berman because of his leadership in so many activities. Harris then went to Harvard, from which he graduated in 1960 with a bachelors degree.

In New York City, where he graduated in 1964 from the Columbia University College of Physicians and Surgeons, Dr. Berman began dating Ruth E. Nemzoff, and they married in 1964.

They had met several years earlier when Ruth was a counselor at a summer camp his sister attended. Later, friends in New York fixed them up on a date.

I think what drew us together was that on our first date we talked about going into the Peace Corps, said Ruth, who has a doctorate in administration, social policy, and planning, and taught for many years at what is now Bentley University. She also has written books about parenting and family relations.

We both were very much attracted to the notion of service and adventure, she said, and that was a theme throughout our lives.

They had four children: Kim of Bethesda, Md., Seth of Cambridge, Rebecca of San Francisco, and Sarabeth of Washington, D.C.

While working with those whose careers he encouraged, Dr. Berman was really good at seeing the big picture. He used to say, Its not a crisis. Its a problem that needs to be solved, " said Rebecca, a physician who followed her father into academia and directs the internal medicine residency program at the University of California, San Francisco.

Beyond being an amazing dad, she said, he also was really a coach and a mentor to me when I started this job.

From middle age onward, Dr. Berman faced a series of health challenges: a heart attack, bypass surgery, kidney cancer, a pacemaker.

He was really a walking testament to miracles of modern medicine, Sarabeth said at his funeral.

As he attended milestone family events, what became clear to me is that he was marking time by the landmarks in my life that he never expected to see, she said. That idea defined my relationship to him and really how he lived. He made the time. He marked the moments. Its not so much that he treated every day like his last day. Its more that he lived purposely and with gratitude.

A service has been held for Dr. Berman, who in addition to his wife and children leaves his sister, Phyllis of Sudbury, and 11 grandchildren.

Dr. Berman was sort of a quiet person who really knew what was right, and what he wanted to accomplish, and set out to do that in a way that was never flashy, Seth said in an interview.

At the funeral, Seth recalled that when he was a boy, his father returned home to share the story of an HMO chief executive who had sold his company and made hundreds of millions of dollars. I asked my father, Arent you jealous? Anyone who knows my father and is older than 14 could probably guess his answer: Why would I be jealous? That is not what I set out to do. This typifies one of my fathers greatest strengths.

Though he achieved great success, Dr. Berman didnt compare his life to others and always took the time to enjoy the view from wherever he was and whatever path he was on, Seth said. When I think of my father, I think of a man who was truly content.

Bryan Marquard can be reached at bryan.marquard@globe.com.

Go here to read the rest:

Dr. Harris Berman, HMO pioneer and former Tufts University School of Medicine dean, dies at 83 - The Boston Globe

PEER certification awarded to College of Medicine and Hershey Medical Center – Penn State News

HERSHEY, Pa. Penn State Universitys College of Medicine and the Milton S. Hershey Medical Center were recently awarded a platinum-level Performance Excellence in Electricity Renewal (PEER) certification from GBCI.

PEER is the worlds first certification program that evaluates the resiliency, reliability and sustainability of participating organizations power systems. The program evaluates the power systems across six categories: reliability and resiliency of power systems; their energy efficiency and environmental impact; the operation, management and safety of these systems; grid services; innovation and exemplary service; and regional priority of the energy systems.

Since 2010, Hershey Medical Center has been working towards creating a more sustainable power system by implementing an Energy Conservation Program. Through this, the Medical Center has been able to reduce its energy consumption by 20%. This led to monetary savings and a carbon output reduction.Not only does the increased reliability and sustainability help the environment, but it also increases healthcare resiliency, or the persistence of high-quality healthcare.

As a healthcare provider, Hershey is unable to stop operations in the event of a power outage. In order to continue providing lifesaving medical care, it is critical that they have uninterrupted access to a fully functional power grid, equipped with backup systems in the event of power failures. To evaluate its energy infrastructure and performance, the Hershey Medical Center pursued PEER certification.

The PEER Certification process forced us to step back from the day-to-day tasks of operating and maintaining the campus infrastructure to support the Milton S. Hershey Medical Center mission, and holistically consider the campus as a microgrid and the future of renewable energy and sustainability possibilities, said Kevin Kanoff, campus energy engineer.

The achievement of the platinum PEER certification from GBCI is the highest possible award an important honor and signifier of their commitment to energy efficiency and reliability. Out of 110 available points, Hershey Medical Center earned 85. One infrastructure project that helped to achieve these ratings isthe Combined Heat and Power unit which supplies 75% of Hershey Medical Centers energy requirement. The Hershey Medical Center also met the goals of supplying an alternative power supply for 100% of all project loads and updating and optimizing HVAC and lighting systems to be more efficient.

The PEER Certification process provided us with the means to further evaluate our environmental performance through established metrics, identify areas where we have excelled and more importantly where there are opportunities for improvement as we strive to be a leader in environmental practices within the health care industry, said Mark Heisey, facilities compliance program manager and Campus Sustainability Council Environmental Subcommittee co-chair.

With these projects, Hershey Medical Center was able to increase fuel efficiency use from 51% to 75%, mitigate around 55,000 MWh of electrical supply and distribution losses, and reduce the centers electricity production related carbon emissions by 10%.

Improvements such as theseprovide greater potentialto reduce the impact of the center on the environment, and in addition, to have a positive impact on the communitys health and well-being. With reduced carbon emissions,localhealth effects related to pollution and warminghave the opportunity for reduction as well. In addition, it helps to increase the reliability of the medical center, with improvements to the power grids capability to withstand an increase in storms and extreme weather events related to climate change. Reduced costsare also likelyto improve the quality-of-care patients receive, as money saved could be spent making further improvements.

We are committed to a holistic framework that addresses the efficiency and effectiveness of our electrical system. said Marvin W. Smith, CHFM assistant vice president, facilities, Penn State College of Medicine, Penn State Health Milton S. Hershey Medical Center, Through PEER certification, we demonstrate dedication to reliability, resiliency and the environment.

Read more here:

PEER certification awarded to College of Medicine and Hershey Medical Center - Penn State News

Medicine must stop using race and ethnicity to interpret test results – New Scientist

By Layal Liverpool and Jennifer Tsai

Roberto Cigna

SHOULD your race or ethnicity influence the prescription you get from your doctor? Both are still used in medicine to interpret test results and guide treatment decisions, but the evidence is questionable and the approach can cause serious harm.

Medical guidelines in the US, UK and elsewhere often recommend the use of algorithms that contain adjustments for a persons race or ethnicity, from tools used to assess bone fracture risk to devices containing embedded racial or ethnic adjustments for measuring lung function. The latter can be partly traced back to the suggestion by US slaveholder Samuel Cartwright in the 1800s that Black people had naturally low lung capacity and so were healthier when enslaved.

These algorithms are finally coming under significant scrutiny. Recently, the US National Kidney Foundation and the American Society of Nephrology formally established a consensus against the use of race adjustment in kidney function equations. A similar race-based kidney test adjustment was also removed from UK medical guidance set by the National Institute for Health and Care Excellence (NICE). These decisions came in response to growing concerns that the race adjustment was contributing to underdiagnosis and undertreatment of kidney disease among Black people.

Yet race-based decisions are still permeating other parts of medicine with little evidence to support them. NICE, for example, has declined to review its guidance on high blood pressure treatment that recommends different drugs for Black people compared with everyone else. The guidance currently says that doctors should prescribe drugs called ACE-inhibitors to people under the age of 55 with high blood pressure unless they are of black African or African-Caribbean family origin, in which case they should receive different drugs.

Dipesh Gopal, a general practitioner who is also at Queen Mary University of London, and his colleagues have written to NICE twice over the past year requesting an urgent review of this guidance, but it declined in both cases, responding that evidence suggests there are clinically meaningful differences in the effectiveness of treatments for individuals in these family origin subgroups.

But Gopal and others dispute this evidence, particularly given that race and ethnicity are poorly defined social constructs with no biological basis. Indeed, according to the data, peoples treatment responses quite literally arent black and white.

In response to Gopal and his colleagues, and to the content of this article, NICE said that there is not a clear-cut biological and genetic homogeneity amongst all Black and White people and that the guideline does not account for people with mixed heritage. But it said performing the relevant tests on everyone wasnt possible due to the expense, and the additional time.

Using race or ethnicity as an indicator of biology in this way is lazy and imprecise. NICE and other health organisations globally should start systematic reviews of race-based recommendations across their guidelines immediately. A doctors glancing assumption about a persons race or ethnicity doesnt offer meaningful biological information that can guide medical decisions. They arent biological variables and cant be used as a proxy for genetic make-up.

This doesnt mean medicine should become colour blind. Racism clearly drives health inequities in many countries and this must be addressed. But perpetuating harmful and unscientific ideas about biological differences between races in medical guidance isnt the solution.

More on these topics:

Link:

Medicine must stop using race and ethnicity to interpret test results - New Scientist

Temple works to increase the number of Black men in medicine – Temple University News

Black male physicians at Temple gathered in the Lewis Katz School of Medicines Medical Education and Research Building on Nov. 5 for the third annual Evening for Black in Men Medicine: an event celebrating the achievements of and offering mentorship opportunities for Black premedical and medical students as they make their way into the medical field.

The evening was part of the Office of Health Equity, Diversity and Inclusions efforts to recruit, support, retain and advance high-quality medical students from backgrounds that are historically underrepresented in medicine, as well as to specifically address the ongoing shortage of Black men in medicine.

Black male medical students accounted for just 3.1% of the national medical student body in 1978. By 2019, the figure had declined to 2.9%. And the number of Black male matriculants to medical schools for more than 40 years has not surpassed the numbers in 1978.

According to a 2015 report by the Association of American Medical Colleges, there were 542 Black male matriculants in medical school in 1978. That was reduced to 515 in 2014.

Participants at An Evening for Black Men in Medicine. (Photography by Joseph V. Labolito)

The participants in attendance represented a range of Black male doctors from the Katz School of Medicine, Temple University Health System and the Greater Philadelphia region. Alongside them were pre-med students identified through Temples Pre-professional Health Studies Office, primarily from Temple and other local area colleges and universities, plus Temple medical students.

Abiona Berkeley, the interim senior associate dean of diversity, equity, and Inclusion at the Katz School of Medicine, and Amy Goldberg, the schools interim dean, were the first two speakers at the event.

Steuart Wright, a Black medical student at Temple, introduced Temple President Jason Wingard as a guest speaker.

During President Wingards speech, he asked the group questions like, What is the responsibility of Black men in medicine? and, Why do we need to increase the number of Black men in medicine?

The reason why were having this interactive dialogue is first to listen, to better understand what the communitys needs are and what the physicians or the aspiring physicians needs are,'' he said. You have to use the resources available to you. Build relationships. Secure resources, financial and intellectual, and identify stakeholders of all kinds, then put it all into practice and dont be afraid to take risks.

We have a commitment and a responsibility to the community, added President Wingard.

Wingard noted that there have been financial barriers for Black men trying to pursue a path in the medical field, as well as not having the background or the necessary resources.

One of the participants in the room asked President Wingard what he will do to help forge a tighter connection between the university and the community to make it easier for Black physicians to serve the community.

I'm going to listen, execute fearlessly, leverage our resources, raise money and apply it to the places in need. We want this room to be full of Black men in medicine, said President Wingard. We want Philadelphia and Temple University to be the leaders in dialogue around this topic.

Also speaking at the event was Provost Gregory N. Mandel, who said one of Temples primary goals is to provide education that is affordable and accessible to a diverse student body.

Many people face not having a parent who was in the health profession, so they may not know the steps to take. We are thinking about how to get information out in order to provide a support system with both a diverse and inclusive environment where everyone can participate, said Mandel.

Deric C. Savior served as the keynote speaker at the Evening for Black Men in Medicine event. (Photography by Joseph V. Labolito)

Deric C. Savior, head of the medical oncology section in Fox Chase Cancer Center at Temple University Hospital and an associate professor in the Department of Hematology/Oncology, also spoke with the group.

Savior specializes in treating lung, head and neck cancers and has earned recognition from Best Doctors in America and Medical Oncology and Hematology in 20152016 and 20192020 and Top Doctors, Medical Oncology and Philadelphia magazine in 20182021.

Savior added to his list of accomplishments by receiving the 2021 Black Men in Medicine Award at Temple.

Following the presentations, the participants gathered for conversation and networking over dinner in the Medical Education and Research Building.

See original here:

Temple works to increase the number of Black men in medicine - Temple University News

How to uncover your purpose and thrive in veterinary medicine – DVM 360

In a recent interview with dvm360, Dr Mia Cary revealed pointers on how veterinary professionals can lead successful career paths, starting with formulating a purpose.

At the Atlantic Coast Veterinary Conference (ACVC), Mia Cary, DVM, compiled a list of her top 3 ways that can help veterinary professionals become successful within their career, plus highlights a few resources professionals can utilize to get started.

View the video below for the entire discussion. The following is a partial transcript:

Mia Cary, DVM: When I launched my own business, I spent a lot of time thinking about what matters most to me, and I created a personal purpose statement that also became my professional purpose statement. [My purpose statement] is simply activating others to thrive, and that allows me [to decide] what to say yes to, and what to say no to. So, I think knowing your purpose is extremely important.

Read this article:

How to uncover your purpose and thrive in veterinary medicine - DVM 360

Scipher Medicine to Present at the Jeffries London Healthcare Conference – Business Wire

WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced that Alif Saleh, Chief Executive Officer, and John Strumbos, Chief Financial Officer, will participate in the Jeffries London Healthcare Conference, November 16-19.

Scipher Medicine will present from London at 10 a.m. GMT on Tuesday, November 16, and management will be available for in-person and virtual investor meetings during the conference. A live webcast of the conference presentation will be available here.

About Scipher Medicine

Scipher Medicine, a precision immunology company matching patients with their most effective therapies, believes that patients deserve simple answers to treatment options based on scientifically backed data. Using spectra, our proprietary network medicine platform, and artificial intelligence, we commercialize blood tests revealing a persons unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. We partner with leading payers, providers, and pharmaceutical companies to bring precision medicine to autoimmune diseases. Visit http://www.sciphermedicine.com and follow Scipher Medicine on Twitter, Facebook, and LinkedIn.

See the article here:

Scipher Medicine to Present at the Jeffries London Healthcare Conference - Business Wire

Disc Medicine Announces Oral Presentation on Bitopertin at the 63rd American Society of Hematology Annual Meeting – PRNewswire

CAMBRIDGE, Mass., Nov. 11, 2021 /PRNewswire/ --Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases, today announced that the company and its collaborators at Boston Children's Hospital have been selected to give an oral presentation at the upcoming 63rd American Society of Hematology (ASH) Annual Meeting and Exposition, which will be held in Atlanta, GA on December 11-14, 2021.Disc will present data from studies of bitopertin, the company's orally available glycine transporter 1 (GlyT1), in preclinical models of Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP).

Details of the presentation are as follows:

Abstract Number:760

Title:Proof of Mechanism Studies with Bitopertin, a Selective Glycine Transporter 1 Inhibitor Under Development for the Treatment of Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLPP)

Date / Time:Monday, December 13, 2021: 5:15 PMSession:102. Iron Homeostasis and Biology: Disorders of Iron and Heme and Novel treatments Presenter:Paul Schmidt

Full abstract currently available through the ASH conference website: https://ash.confex.com/ash/2021/webprogram/Paper150441.html

About Bitopertin

Bitopertin is designed to be an oral, potent, and selective inhibitor of GlyT1, a key membrane transporter required to supply developing red blood cells with sufficient glycine to support erythropoiesis. Glycine is an essential component of heme and by limiting glycine uptake in newly forming red blood cells, bitopertin is designed to modulate heme biosynthesis to potentially treat a range of hematologic disorders associated with the biosynthesis of heme and hemoglobin. Bitopertin has been evaluated in a comprehensive clinical program focused on certain neurological disorders conducted by Roche in over 4,000 individuals, which demonstrated the activity of bitopertin as a GlyT1 inhibitor and suppressor of heme biosynthesis. In preclinical studies in human and animal models of erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), bitopertin was shown to significantly decrease PPIX, a toxic intermediate of heme synthesis that is the underlying cause of the disease. Disc Medicine is planning to develop bitopertin as a potential treatment for patients with EPP and XLP as well as a range of other hematologic diseases. Bitopertin is an experimental agent and is not approved for use as a therapy in any jurisdiction worldwide.

About Disc Medicine

Disc Medicine is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. We are building a portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. For more information, please visit http://www.discmedicine.com.

SOURCE Disc Medicine

More here:

Disc Medicine Announces Oral Presentation on Bitopertin at the 63rd American Society of Hematology Annual Meeting - PRNewswire

‘Laughter the best medicine to move away from COVID’ – SooToday

Comedian Pete Zedlacher performs in Sault Ste. Marie on November 27 at Soo Blaster

If anyone needs a laugh right now, its everyone.

With Covid quarantines and lockdowns behind us for now, stand-up comic Pete Zedlacher has been back on stage and is noticing that laughter really is the best medicine.

Im getting so many compliments after the shows with people saying I didnt realize how much I missed other human beings in an experience watching a comedian perform and sharing the laughter, he said.

It really reminds us that we are all part of this big tribe and being separated from each other has been very trying.

Zedlacher will be performing in Sault Ste. Marie on Nov. 27 at Soo Blaster.

Born and raised in Wawa, Zedlacher has fond memories of driving into the Sault as a boy, seeing the bright lights of the city and the water tower.

Sault Ste. Marie was a big city to me. It was exciting when I got to the Sault, he said.

Soon as I saw the water tower coming in and then the stop lights. Oh my God it was exciting. And then youd go to the Station Mall and ride the escalators at Sears. It was all very exciting.

But, seriously, folks, Zedlacher, who now lives in Calgary, says getting back to live shows couldnt come soon enough.

Just as many saw their workplaces move online, so did Zedlacher, and hes had about one Zoom call too many.

I did some Zoom shows where you perform stand-up comedy into your laptop and people tune in from their living rooms, and it sounds just as fun as Ive described, he said.

People are not apt to laugh while theyre staring into their laptop. When you put a wi-fi signal and two screens in front of it, its very removed."

Inspired by comedians like David Letterman and television shows like Saturday Night Live, there is one true comic that stands out as having influenced Zedlachers decision to become a comedian Fozzie Bear.

I was a very little boy, and I was watching The Muppet Show and Fozzie Bear said he was a comedian and I turned to my mom and said, What does that mean hes a comedian? and my mom told me thats his job, thats what he does, he makes people laugh, and she said I sat there for a couple of seconds and nodded and said, Yup, Im going to be a comedian.

Fast forward 30 years to a Just For Laughs comedy festival that brought it all full circle for Zedlacher.

The Muppets are hosting the gala and I had to follow Fozzie Bear. Im in the wings and Im watching Fozzie Bear warm up the audience before I hit the stage, he said.

Zedlacher has won many awards including a Canadian Comedy Award for Best Male Standup and a Sirius XM Top Comic Award. He has had multiple Canadian Comedy Award nominations and two Gemini nominations.

Besides stand-up comedy, Zedlacher also has many credits in television writing and acting. Highlights include The Ron James Show, The Hour With George Stroumboulopoulos, The Jon Dore Television Show, and CBC Radios The Debaters.

Zedlacher also appeared on a few episodes of Degrassi: The Next Generation, playing a cop alongside Aubrey Graham, aka Drake.

Zedlacher jokes about that time, saying he encouraged Drake to pursue his musical dreams after the then-actor said he wanted to try his hand at rap and hip hop.

I told him he should do it. And he said yeah? And I said yeah, youve got a real shot at it and he looked at me and said thanks, man, and I said, cool, and you know, two years later hes Drake. Hes like the biggest recording artist in Canadian history and he still has not thanked me.

Zedlacher is looking forward to his show in the Sault in a few weeks and hopes many will get out of the house and share in the laughter.

I cant stress enough how important that is for us as human beings to share in moments like that, he said.

Theres nothing like being in a comedy audience and theres that loud laugher off to your left who makes you laugh even harder, and just the energy in the room between the performer and the audience. Its a magical experience that cant be matched on Netflix or CBC Radio, you know, its got to be seen live.

See original here:

'Laughter the best medicine to move away from COVID' - SooToday

Dr. Simone Reveals an Off-Camera Moment with Dr. Jackie That Helps Get to "The Core" of Their Issues – Bravo

Married to Medicine reunions always have a way of making our jaws drop, and the Season 7 sit-down was no exception. Dr. Simone Whitmore and Dr. Jackie Walters surprised everyone when they revealed that the events of the season, including the drama with Buffie Purselle and its aftermath, had put a major strain on their relationship.

But, as also tends to be the case at Married to Medicine reunions, the group rallied around the pair and brought them back together. Dr. Simone and Dr. Jackie hugged and shared their commitment to getting their friendship back on track.

Fast forward to the beginning of Season 8, and the OBGYNs were still not in a good place. But after some time passed, Dr. Simone and Dr. Jackie did eventually find their way back to one another, and an emotional conversation appeared to ease the tension between the two. This time, the reconciliation seemed to stick.

During Part 2 of the Married to Medicine Season 8 reunion, which aired on July 11, Dr. Simone gave an update on where she and Dr. Jackie stand today. "Well, we are in a much better place, and we talk, we study together still," Dr. Simone explained. "And, you know, the fact is I don't harbor any ill feelings about Jackie. I love Jackie. I will always love Jackie."

When it came to why she and Dr. Simone didn't follow through on their promise to repair their relationship after the Season 7 reunion, Dr. Jackie said, "Life got in the way. And when you don't work on a relationship and I think this is for everybody it falls apart."

Dr. Simone then explained why she didn't invite Dr. Jackie to son Michael's graduation party this season, which took place before they had made up. "I just, we were awkward," Dr. Simone said. "It was a close gathering with close friends, family. I didn't want anything to be awkward."

Host Andy Cohen pointed out that Dr. Simone had invited Anila Sajja to the event, whom she had only recently met. "That's where I got super offended is when Anila got invited," Dr. Jackie said, to which Dr. Simone replied, "But she was the only person there, the only person there that was not part of my close circle."

Dr. Simone also addressed Quad Webb's comments on Watch What Happens Live with Andy Cohenearlier this season in which she questioned if her reconciliation with Dr. Jackie was genuine. "First of all, you used the word 'fake,' as if we made up strictly for TV. It's not something I would do," Dr. Simone said. "And so I came to Jackie from a genuine place when I spoke to her. But we have some difficult topics that we need to tackle."

"You don't just get back to normal overnight with a hug," Dr. Simone added. "At least I don't."

Dr. Jackie shared that she felt like Dr. Simone hasn't had her back the way she has for Toya Bush-Harris. "What I said to Simone is I noticed she has developed the ability to ride for Toya no matter what. And no disrespect to Toya. Toya can say 'achoo' and Simone has an explanation for it," Dr. Jackie said. "What I had hoped for Simone last year is when I was being crucified by the situations that I was in with the people who aren't here today, that Simone would've ridden for me like that."

Dr. Simone said that she felt like she had been there for Dr. Jackie after that explosive dinner during the trip to Mexico last season. "I came to you in Mexico I'm not gonna play this game with you with no f--king camera around to say you responded at dinner in a way that is not you. I need for you to fix it," she recalled. "I came to your hotel room, no microphone, no camera, and said that s--t last night doesn't represent you. I said it to you."

But Dr. Jackie said that she didn't feel the support from Dr. Simone in that moment. "And did I not explain to you why I reacted? I said, 'Simone, that wasn't the place. It was your dinner.' And never did you go back to the group and say, 'That ain't who Jackie is,'" Dr. Jackie shared. "Petty as it is, I did take offense to that, and that is part of why we haven't healed is we have not been able to deal with the hard stuff."

Dr. Simone admitted, "I should have said it out loud."

The real root of Dr. Simone and Dr. Jackie's issues was now starting to become clearer, according to Andy. "It sounds like we're getting to the core of when this all went left," he said. "You're not getting what you need from each other in terms of the other backing you up and defending you."

Of course, Dr. Simone's conflict with Dr. Heavenly Kimes has also been connected to all of this. When it comes to the current status of her friendship with Dr. Simone, Dr. Heavenly said at the reunion, "I don't speak to Simone. Simone doesn't speak to me."

Andy went on to ask Dr. Simone if she felt like she and Dr. Heavenly could once again have thatclose bond they shared while the OBGYN was going through her marital issues. "Let me say that I would love to be back in that place with Heavenly, but it's difficult for me as a sensitive person to read and hear about all the bulls--t and sensitive stuff she says about me on the regular," Dr. Simone said, later specifying that she has heard Dr. Heavenly, who is a dentist, make negative comments about her teeth. "That, I don't want those kind of friends."

Dr. Simone noted that she thinks she could be friends with Dr. Jackie while she's still close to Dr. Heavenly "once Heavenly and I are back in a better place." "I've been trying. I've called you over and over again, Simone. You know I have," Dr. Heavenly said in response (clip above). "You have not put up any effort."

Dr. Simone admitted that it's been challenging for her to be able to move forward with Dr. Heavenly. "I had a close relationship with Heavenly, and Jackie knows it. But when I fall down and out with people, I fall hard," she said. "It's hard to let go of stuff."

However, Dr. Simone does want to get her friendship with Dr. Heavenly back on track and even described herplans to do so once they all get back home to Atlanta. "What I told Heavenly is I missed her birthday party and told her I couldn't come. And I am going to celebrate her birthday when we get back to Atlanta, and I get past some personal things," Dr. Simone shared, adding that she would also like Dr. Jackie to be there.

The Married to Medicine Season 8 reunion continues with Part 3 on Sunday, July 18 at a special time of 10:15/9:15c.Want more Married to Medicine? Catch up on the Bravo app.

The Daily Dish is your source for all things Bravo, from behind-the-scenes scoop to breaking news, exclusive interviews, photos, original videos, and, oh, so much more. Subscribe to The Daily Dish podcast, join our Facebook group, and follow us on Instagramfor the latest news hot off the presses. Sign up to become a Bravo Insider and be the first to get exclusive extras.

View original post here:

Dr. Simone Reveals an Off-Camera Moment with Dr. Jackie That Helps Get to "The Core" of Their Issues - Bravo

Therapy dog bringing a different type of medicine to BRG patients – WBRZ

BATON ROUGE - A service dog is bringing comfort and relief to those recovering at Baton Rouge General.

Fin and his owner Frank walk around the hospital seeing nurses and patients, especially Jimmy Santangelo.

When Jimmy was diagnosed with acute lymphoblastic leukemia he and his wife were not sure how to cope until the four-legged expert came in.

"Frank walked in and then her eyes lit up. She got a whole different attitude a whole different personality," Jimmy said.

"That was kinda a turning point for me, you know just being able to let it all out, in a good way, a good positive way that I didn't feel like was going to upset him. I was just laughing and crying at the time," said Jimmy's wife, Mickey Santangelo.

From there the relationship flourished. Every time Jimmy comes back to Baton Rouge General for chemo treatment Fin and Frank make a visit.

"I know every time I come up here, they'll make it a point to just sit with us and we just get to love on him," Mickey said.

"We got pets and dogs at home, it gives me the sense that I'm at home," Jimmy said.

For Frank, he says that's exactly their goal: to provide stress-relieving medicine to hospital patients and staff every day.

"I just feel blessed that we are a part of it and we're just doing what God wants us to do," Frank said

Dr. Fin and Frank will keep providing that joy as long as they are allowed to. Frank and Fin visit multiple hospitals across the area and also serve at Healing Place Church.

Continued here:

Therapy dog bringing a different type of medicine to BRG patients - WBRZ

Book Review: The History of Animal-Based Medicine in China – Undark Magazine

Liz P.Y. Chee vividly remembers the first time she visited a bear farm. It was 2009, and Chee, who was working for a Singapore-based animal welfare group, flew to Laos to tour a Chinese-owned facility. The animals Chee saw were hardly recognizable as bears, she later wrote, because they had rubbed most of their fur off against the bars of the cages and had grown very long toenails through disuse of their feet.

As at countless other bear farms across China and Southeast Asia, the bears there were being held for their bile. Bear bile which is either milked through a catheter permanently inserted into the animals gall bladders or extracted by stabbing large needles into the animals abdomens is popularly prescribed across the region to treat a host of ailments, including, most recently, Covid-19. It is also marketed as an all-around health tonic. Although there is a growing animal welfare and anti-bear farming movement in China, the industry remains powerful.

BOOK REVIEW Maos Bestiary: Medicinal Animals and Modern China, by Liz P. Y. Chee (Duke University Press Books, 288 pages).

Seeing the suffering bears made Chee wonder about the cultural and historical forces that brought the animals there a question that propelled her to conduct exhaustive research on animal medicalization in China. In Maos Bestiary: Medicinal Animals and Modern China, she details her findings, many of which are distilled from sources never before published in English. Chee, who is now a research fellow and lecturer at the National University of Singapore, also found that, until now, even scholars in China have dedicated scant attention to the history of animal-based medicine, despite the controversy associated with the topic today.

If Chinese medicine retains an Achilles heel in the present century, it is the widespread perception that it is contributing to a holocaust among wild creatures, Chee writes, and in so doing supporting a global criminal enterprise of animal poaching and trafficking. Moreover, she adds, such medicines are often condemned as being as ineffective as they are unethical, even by some Chinese physicians. Many of these products are medically useless at best, Chee writes, and in some cases, actually harmful.

Defenders of animal-based Chinese medicine often point to the practices 2,000-plus year history. In Maos Bestiary, however, Chee shows that the roots establishing the use of most animals as ingredients in medicine are not as deeply planted in Chinas culture as many believe. Instead, the industry as it exists now was purposefully developed, expanded, and promoted over the last century. Today, it is more closely linked to politics and profit than to ancient culture and tradition. This revelation has important implications for both species conservation and for public health, Chee argues, because it leaves room for possibilities of choice and change.

Chee focuses on the evolution of animal-based medicine throughout the tumultuous period of modern Chinas formation, from the 1950s through the 1980s. These decades encompassed the early years of the Peoples Republic of China, Maos Great Leap Forward and Cultural Revolution and, finally, Deng Xiaopings reforms.

While animal-derived medicines do have a long history in China, Chee found that their use in the past was nowhere near the startlingly abundant level they are at today. Around 400 animals were cited in the 16th century Compendium of Materia Medica, for example, whereas more than 2,300 are listed today in pharmacopeias.

Many newly medicalized species exist only on distant continents, such as jaguars in South and Central America. Nor is Chinas use of animals in traditional medicine solely based on Chinese innovation, Chee found; ideas, approaches, and technologies from the Soviet Union, North Korea, Japan, and the Western world all heavily influenced the industrys development. So while animal-based products may still hold the aura of tradition, Chee writes, in fact, most are the products of a profit-driven expansion.

Animal-based medicines are often condemned as being as ineffective as they are unethical, even by some Chinese physicians.

Efforts to abolish traditional medicine and replace it with a science-based approach, primarily inspired by Japan, began in the 1920s and continued through the early days of a Communist government that was racing to build an industrialized economy. While researchers acknowledged that some especially efficacious Chinese herbs were worth investigating to find their active ingredients, animal-based remedies were initially undervalued and underdeveloped by the new regime as it worked to build up its pharmaceutical sector, Chee writes.

Traditional doctors pushed back on the attempt to phase out their industry, however, and argued that the synergistic effects of the plant, animal, and mineral ingredients of their practice were too complex to be nailed down in a lab. To appease both groups, the state-owned drug-making sector decided that doctors trained in Chinese and Western medicine should learn from each other, scientizing Chinese medicine and seeking new innovations from tradition.

To learn from the Soviet Union was also a popular phrase in China at this time. Following the example set by the USSR, China was especially interested in creating its own pharmaceuticals from local ingredients to become self-sufficient. Soviet interest in animal-based folk medicine and the USSRs own practice of farming deer for medicinal ingredients soon provided modern and scientific sanction for the Chinese fascination with faunal drugs, Chee writes.

During the Great Leap Forwards period of rapid industrialization, animals as well as plants were swept up in this nationwide project, Chee continues. China expanded its export of high-end medicinal products like deer antler, rhino horn, and tiger bone, especially to Chinese expatriates. To meet steep quotas, authorities promoted the creation of laboratory farms for scaling up production. Entrepreneurs at these farms were also encouraged to find more uses for existing animal parts, and to engineer additional uses for new parts and species.

Once a medicinal animal was farmed, there was pressure or incentive to justify the use of all of its parts, regardless of previous traditions that had often been quite selective as to which part should actually be taken as medicine, and for what purpose, Chee writes. Medicine farms popped up for a host of additional species, including geckos, ground beetles, scorpions, snakes, and seahorses.

Chee shows that the roots establishing the use of most animals as ingredients in medicine are not as deeply planted in Chinas culture as many believe.

Wildlife farming also began being presented as something benefiting conservation because it allegedly spared wild animals from being hunted. In fact, it usually had the opposite effect by stimulating the market and relying on hunters to replenish farm stocks, Chee notes. While she does not delve deeply into the impact this has had on animal populations within and outside China, many sources today argue that demand for traditional medicine all but emptied the countrys forests of tigers, pangolins, and other highly sought after species.

During the purges and upheavals of the Cultural Revolution, the export of luxury medicines such as rhino horn were scaled up to generate much-needed revenue. Back home, however, a stark lack of medical care and supplies inspired an emphasis on miracle cures derived from cheaper, more common animals.

Chicken blood therapy the direct injection of chicken blood (from live chickens) into human bodies was representative of this time, Chee writes. The doctor who founded the treatment claimed chicken blood therapy could cure more than 100 conditions, and it was heavily promoted throughout the country, becoming emblematic of economical grassroots innovations and the very expression of red medicine, Chee writes.

This practice started to be phased out in 1968 when news surfaced of people dying after being injected with chicken blood. But similar remedies soon took its place, including ones that used goose or duck blood, lizard eggs, or toad heads. These new remedies were marketed as magic-like cures for serious and otherwise untreatable conditions, including cancer an attribute that has become standard in the marketing of many animal-based drugs today, Chee writes.

After Deng came to power in 1978, wildlife farming and animal-based medicine became even more popular as part of the official policy to enrich farmers, Chee continues. The government-supported bear bile industry which was originally inspired by facilities in North Korea and continues to flourish today was one major result of this period, as was the proliferation of tiger farms.

Policy shifts also had significant ramifications for the regulation of Chinese medicine, and its impact on consumers and the environment. The forestry ministry was given decision-making power over wild medicinal animals, Chee writes, and would essentially manage Chinas forests as extraction sites. Meanwhile, the health ministry only had full regulatory control of patented drugs, so companies selling animal-based medicines could bypass health or efficacy regulations and make extravagant, unchallenged claims about their products curative value.

Undark is a non-profit, editorially independent magazine covering the complicated and often fractious intersection of science and society. If you would like to help support our journalism, please consider making a tax-deductible donation. All proceeds go directly to Undarks editorial fund.

Give Now

Chinese medicine has become globalized over the last three decades, and animal-based products have continued to play a central, if increasingly problematic, role, Chee writes. The industry is assailed in the international media for its role in driving species declines, and clashes regularly occur within China between proponents of animal-based medicines and those who value wildlife and conservation. Many middle-class Chinese, both on the mainland and in the diaspora, and within Chinese medicine itself, have been on the front lines in the battle to save endangered species from poaching and consumption, Chee points out.

Maos Bestiary went to press in the midst of the Covid-19 pandemic, and Chee writes in the introduction that the likely link between Covid-19s emergence and wild animals fundamentally changes the debate by making wildlife use a global public health issue.

Yet despite the undeniable threats posed by zoonotic diseases, animal-based traditional medicine remains an immensely profitable, and thus politically influential force in China, she continues. As evidence, Chinese authorities not only did not ban animal-based medicine during the pandemic, but actually promoted remedies containing bear bile for treating Covid-19.

As for shaping the industrys future to mitigate the dangers for both wildlife and humans, Chee looks not to officials but to Chinese consumers, who can choose to boycott animal-based medicines. There is a large and growing animal welfare movement in China, so this could be more than just a pipe dream. Whether they will reinvent the pharmacology of Chinese medicine as a practice less reliant on animals, endangered or otherwise, she concludes, remains a vital question.

Follow this link:

Book Review: The History of Animal-Based Medicine in China - Undark Magazine

Alternative medicine: Definition, examples, benefits, and risks – Medical News Today

The term alternative medicine encompasses a wide range of medical practices and systems from cultures around the world. In countries such as the United States, people use it to describe practices that are outside mainstream medicine.

The term alternative medicine is subjective. While doctors in one part of the world might regard a practice as mainstream, doctors elsewhere might view the same practice as alternative.

This article discusses what alternative medicine is, different types of alternative medicine, and whether it is better than conventional medicine.

The term alternative medicine describes any form of medicine or healing that does not fall into conventional medical practice.

In the U.S. it refers to forms of medicine that are not widely accepted or practiced by medical doctors, particularly those that do not have as much scientific evidence to support them as more mainstream methods.

Some types of alternative medicine have been around for hundreds and even thousands of years. Others are quite new. Sometimes, something that begins as an alternative treatment can become part of mainstream medicine due to strong evidence that it works and has no safety risks.

Many people use terms such as alternative medicine, integrative medicine, and complementary medicine interchangeably. However, each term describes something different:

Some people group complementary and alternative medicine together under the acronym CAM. There are many types of CAM. The National Institutes of Health (NIH) group them into five broad categories.

Mind-body therapies focus on the relationship between the mind and body to help treat or manage a condition. Some examples include:

Meditation is an ancient practice that is prominent in religions such as Hinduism and Buddhism. Today, there are many forms of meditation people can try; some are religious in nature, and some not.

Many studies have verified that meditation has health benefits. It can lower blood pressure and stress levels. Research suggests it may also reduce the symptoms of:

Learn more about the types of meditation.

Biofeedback involves the use of machines that measure unconscious or involuntary bodily processes, such as heart rate or muscle contractions. The device then converts the information into audio, visual, or tactile signals. A therapist then helps someone learn to control these signals.

Biofeedback can help people learn to relax painful muscles, alter their mental state, and more. Its most common uses include management of neuromuscular disorders, chronic pain, anxiety, and incontinence.

Hypnosis involves someone going into a deep state of relaxation and focusing on suggestions a clinician makes while the person is in a hypnotic state. The aim is for the suggestions to help change a persons mental state, resulting in health benefits.

According to the American Psychological Association (APA), most clinicians agree hypnosis has benefits for:

Similar to meditation, yoga is a mind-body exercise that originates in spiritual practices. It involves moving through sequences of poses and stretches while also focusing on breathing. Many people around the world practice yoga to promote mental and physical well-being.

Some research suggests yoga may help:

Most studies on yogas benefits have been with small numbers of people, so more research is still needed.

Tai chi is a martial art that originated in China. It involves a series of postures or slow movements combined with controlled breathing. Some research suggests tai chi may help:

Biologically based therapies use substances such as plants and foods to improve health or treat conditions. Some examples include:

Some CAM and integrative practitioners use nutritional supplements, such as vitamins, minerals, or other beneficial compounds, to treat or manage conditions.

This includes the use of plants or plant compounds for medical benefits. There are many examples of plants that people use to treat symptoms or conditions. Popular examples include:

Dietary approaches to medicine involve using food itself to treat certain conditions. This may mean eating foods with specific medicinal properties, following diets that contain certain nutrients, or avoiding some foods altogether.

These therapies aim to help people by manipulating invisible energy fields. According to some medical systems and practices, the energy around the body can influence health. By addressing disturbances or blockages in energy, practitioners believe it is possible to treat certain conditions.

Some examples of biofield therapies include:

This involves a practitioner running their hands over or gently touching someones body to control or restore their flow of energy.

Reiki originally comes from Japan. During reiki treatments, practitioners try to control energy in the body by using their hands. This may involve placing them on someone, just above them, or even working at a distance from a person. The aim is to free blocked energy and improve the bodys natural healing abilities.

Body-based therapies involve a therapist physically moving one or more parts of a persons body for therapeutic benefits. Common examples include:

During massage, a practitioner uses their fingers, hands, or tools to knead, rub, or press the bodys soft tissue. It is an ancient therapy, and people have practiced it in most cultures throughout history. There are many types of massage, each of which involves different techniques, rhythms, and areas of the body.

Reflexology involves pressing or manipulating pressure points in the hands or feet. The idea behind it is that a practitioner can target and help other parts of the body. It can also promote relaxation.

This therapy manipulates someones muscles, tissues, or bones to help the body heal from musculoskeletal conditions or help someone cope with a condition that may be causing pain.

Whole medicine systems refer to sets of beliefs and practices that work together. These systems have typically evolved over hundreds of years. Some of the most well-known methods include:

TCM is a complex system based on a belief in two opposite forces: yin and yang. For the body and mind to be in good health, practitioners believe that yin and yang must be in balance. TCM practitioners use a combination of herbal, mind-body, and physical therapies to achieve this.

TCM is over 2,000 years old and is where practices such as acupuncture and tai chi have their origins.

Ayurveda is a holistic health system that developed in India thousands of years ago. Ayurvedic practitioners believe that everyone is made up of five elements: air, fire, water, earth, and ether (or space). The way these elements combine dictates how the body works.

Homeopathy comes from Germany and is around 200 years old. It focuses on two theories: that like cures like and that the lower the dose is of something, the more effective it is.

There is little evidence that homeopathy works for any condition. Additionally, some substances homeopathy uses are toxic, such as white arsenic and deadly nightshade.

Naturopathy is a system that includes a mixture of traditional and alternative approaches to medicine. It focuses on using natural and noninvasive ingredients and techniques, such as herbs, exercise therapy, dietary changes, and massage, among many others.

In some U.S. states, naturopathic doctors can also prescribe pharmaceutical medications, but this varies based on location.

Many people debate whether conventional medicine is better than alternative medicine. When comparing them, it is important to consider the following:

One of the main benefits of standard medical care is that it undergoes rigorous research. Through clinical trials and studies, scientists can determine whether certain techniques, medicines, and courses of treatment are effective and safe.

Many scientists use these methods to study alternative medicine, too. However, the data is not always as abundant or reliable. Some types of alternative medicine, such as homeopathy, have very little scientific evidence to support them.

There are exceptions to this. Some types of alternative therapy have been well-researched by scientists, so doctors can safely recommend them to patients. Examples of this include yoga and meditation, as well as acupuncture. The American College of Physicians recommends acupuncture as a first-line treatment for lower back pain.

Some people believe that alternative medicine is better than conventional medicine because it often focuses on natural substances, which some believe to be safer, gentler, or more suitable for the human body than manufactured medicines.

However, as with conventional medicines, natural medicines can also cause side effects, drug interactions, and poisoning at the wrong dosages. Some natural products can also contain harmful substances not listed on the label. For example, some Ayurvedic products contain naturally occurring toxins, such as mercury or lead.

Even when natural products are safe, it can be more difficult for companies to ensure they have consistent levels of potency and purity. Third-party testing can reduce this problem, but not all companies use it.

For some, conventional medicine is more difficult to access than the alternative treatments available within their communities. In comparison to the U.S. healthcare system, alternative medicine may be:

These are important factors and can make alternative medicine more appealing. People who have had negative experiences of healthcare may also prefer to seek alternative options.

Alternative medicine refers to medical practices that are not mainstream. In the U.S., people use this term to refer to a wide range of therapies and medical systems, from Ayurveda to reflexology.

Whatever form of treatment a person chooses, it is always important to consider the evidence that supports it, potential risks and side effects, and whether the practitioner is fully qualified. Where possible, always speak with a medical doctor before trying alternative treatments, as they can have risks.

Go here to see the original:

Alternative medicine: Definition, examples, benefits, and risks - Medical News Today

Combining Gamification, Cash Incentive Increases Veterans’ Exercise – pennmedicine.org

PHILADELPHIA We know that turning goals into a game can increase peoples physical activity. We also know that financial incentives can be effective, especially when theyre framed in a way where people lose money if they dont reach their goals. But a new Perelman School of Medicine at the University of Pennsylvania study adds to evidence that combining the two can result in significant gains.

Researchers affiliated with Penn Medicines Center for Health Care Innovation showed that a group of veterans who were overweight or obese and receiving care from a Philadelphia hospital were able to increase their daily step counts by more than 1,200, on average, when their personalized goals were paired with a game in which they received support from a buddy, all while they stood to potentially lose reward money if they didnt hit their targets.

The research, believed to be the first of its kind among veterans, was published in JAMA Network Open.

What our study begins to show is that the combination of varying approaches can be effective, but we need to learn more about the duration and ability to sustain an effect over longer-periods of time, said the studys lead author, Anish Agarwal, MD, a clinical innovation manager in the Penn Medicine Center for Digital Health and an assistant professor of Emergency Medicine.

Often, companies create programs to encourage healthier behavior among employees. These programs typically involve step counts measured by some form of pedometer and daily or weekly goals, but leave it at that. Agarwal believes that its important to study how different framings of goals and the accomplishment of them is important to improving them and actually helping people improve their behaviors.

The world of mobile and digital health has created an environment where rolling these programs out is easier and more interactive, Agarwal said. Time will certainly tell in how these incentives can be used to in equitable and sustainable ways.

For this study, Agarwal and his fellow researchers including senior author Mitesh Patel, MD, an associate professor of Medicine recruited 180 participants. They were randomly assigned to one of three different, equal groups. Everyone, including those in the control group, received an electronic, wearable device to track steps and selected a personalized goal. But two of the groups utilized a behavioral science concept called gamification, in which their goals were tied to a game in which they achieved points and levels for hitting their step goals. The progress of these participants was shared weekly via email with a buddy the participant had designated who could review them and encourage them.

One of those groups, though, had money riding on their goals. In total, they stood to make $120 if they hit their goals each week for the studys 12-week intervention period. Every week that they didnt achieve their goals, the participants lost $10 from the total theyd be issued at the end of the study.

It was this group, the researchers found, who made the largest strides during the intervention period. Compared to the control group, they significantly increased their steps by an average of 1,224. The other gamified group did increase their steps above the control group, but it was only by 433, which was not significant.

Loss aversion is a very powerful motivator, Patel said. Most programs deliver rewards after the goal is achieved, but this clinical trial, similar to previous ones, shows that offering financial upfront and letting participants know they can be an effective strategy.

After the 12-week intervention period ended, the researchers continued to observe participants step counts when the games were turned off. In the eight weeks following, neither group sustained their progress compared to those who were not part of the games. The group with financial incentives did still have an average 564 step increase in their daily totals, but the non-incentive group actually decreased their daily steps by an average of 160.

Agarwal said that more research is needed to determine exactly why they got the results they did when research has supported gamification both with and without financial incentives. Their main focus is to increase the intervention time, and, ultimately, achieve longer term changes.

Next steps for us are to begin to design and test approaches which help sustain the effect beyond the intervention period, Agarwal said. One could imagine varying financial amounts at risk, duration of the intervention, and a strong social incentive. In this study the social incentive was passive, a weekly email to a social support person, but we could imagine more social connection or competition to test for individuals or groups.

This study was funded by a Career Development Award from the Department of Veterans Affairs Health Services and Research Department (HX-001922-01).

Other authors include Kimberly Waddell, Dylan Small, Chalanda Evans, Tory Harrington, Rachel Djaraher, and Ai Leen Oon.

Penn Medicineis one of the worlds leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of theRaymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nations first medical school) and theUniversity of Pennsylvania Health System, which together form a $8.9 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according toU.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $496 million awarded in the 2020 fiscal year.

The University of Pennsylvania Health Systems patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Centerwhich are recognized as one of the nations top Honor Roll hospitals byU.S. News & World ReportChester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nations first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 44,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2020, Penn Medicine provided more than $563 million to benefit our community.

Follow this link:

Combining Gamification, Cash Incentive Increases Veterans' Exercise - pennmedicine.org

New Clinical Study Investigates Using Integrated Diagnostics to Enable Precision Medicine for Liver Cancer Patients – Business Wire

OXFORD, England--(BUSINESS WIRE)--Perspectum is pleased to announce that a new prospective, observational, cohort study called Precision medicine for liver tumours with quantitative magnetic resonance imaging and whole genome sequencing (Precision1, NCT04597710) is underway. Participants with primary or secondary liver cancer will be recruited from Hampshire Hospitals NHS Foundation Trust in Basingstoke. Perspectum will also partner with experts in clinical applications of genomic sequencing in patients with cancer from the University of Oxford.

In the study, Perspectums Hepatica imaging technology will be integrated with clinically actionable whole genome sequencing biomarkers and digital pathology results to disrupt the cancer care pathway.

The Hepatica report provides hepatobiliary surgeons with quantitative metrics that can be employed to evaluate a participants overall liver health prior to surgery. Based on these quantitative liver tissue characteristics, the surgeons will assess whether to modify their participants existing surgical plan (Mole et al., 2020, Sethi et al., 2021). Once the participants liver cancer is surgically removed, Perspectum will collect and prepare the tumour tissue for whole genome sequencing (WGS) and analyse the data using the bioinformatics pipeline developed by University of Oxford.

Mr Myrddin Rees OBE, consultant hepatobiliary surgeon at Hampshire Hospitals NHS Foundation Trust, says, We are delighted to be part of this innovative study. Knowing the wellbeing of the liver is crucial to enable us to plan liver surgery. Linking that to the genomic make-up of the tumours is likely to guide us to accurately predict which patients will benefit from surgery and how much liver tissue could be removed safely in each patient.

University of Oxfords Dr Sarah Gooding says, Precision1 will investigate how AI may support clinical decision making, by integrating and scoring complex genetic, digital pathology and imaging data, in the management of liver metastases. This is a tremendously exciting blueprint for improving clinical decision making in the big data age. Mr Rees adds, This could represent another key step towards personalised care for patients with both primary and secondary cancer in the liver.

This study is funded as part of the Innovate UK/UKRI Data to Early Diagnosis and Precision Medicine Challenge (project number 50234).

About Perspectum

Perspectum, a global medical technology company with offices in the U.K., the U.S. and Singapore, delivers leading digital technologies that help clinicians provide better care for patients with chronic metabolic diseases, multi-organ pathologies and cancer. With a strong focus on precision medicine using advanced imaging and genetics, our vision is to empower patients and clinicians through quantitative assessments of health enabling early detection, diagnosis and targeted treatment. With a diverse team of physicians, biomedical scientists, engineers and technologists, Perspectum offers a way to manage complex health problems at scale.

See the article here:

New Clinical Study Investigates Using Integrated Diagnostics to Enable Precision Medicine for Liver Cancer Patients - Business Wire

Residents and Faculty Honored During McLeod Family Medicine Residency Graduation – McLeod Health

McLEOD REGIONAL MEDICAL CENTER 8 JULY 2021

A graduation for the 39th McLeod Family Medicine Residency Program was held on June 25. The Class of 2021 included Dr Caitlin Basnight, Dr. Aria Behrouzi, Dr. Eric Hart, Dr. James Johnson, Dr. Narjah Martin, Dr. Brice Morey, Dr. Yorke Reynolds and Dr. Brandon Washington.

This class represents the 39th class to graduate from our program, said Dr. Gerard Jebaily, McLeod Family Medicine Residency Program Director. At 60 percent, we have the highest retention rate of Residents who have remained in South Carolina to practice, the highest rate in the state. We are very proud of our program and its graduates.

During the graduation ceremony, Dr. Eric Hart was presented with the 2021 Society of Teachers of Family Medicine Residents Teacher Award for exemplifying skills and interests in teaching. The recipient of this award, chosen by program faculty, excels in precepting medical students, community and peer teaching, patient education, and presentations given at regional family medicine meetings. Dr. Hart will join the McLeod Medical Staff as a Hospitalist at McLeod Regional Medical Center starting in August.

Dr. Richard R. Howell was also named the 2021 recipient of the Halford Award for Leadership in Humane Education by South Carolina AHEC and McLeod Health. The award was presented to Dr. Howell by Dr. Jebaily and Dr. Allan Macdonald, Associate Program Director. Since 1984, Dr. Howell has been an integral part of the Family Medicine Residency Program at McLeod Regional Medical Center serving as the Director of Geriatric Education. Recently, Dr. Howell was named Program Director for the McLeod Family Medicine Rural Residency Program. The Halford Award is presented to a Family Medicine Residency Training Program Faculty Member in recognition of outstanding leadership in providing humane education. The award is named for Dr. James Halford, who was the founding director of the AnMed Health Family Medicine Residency Program. Award winners demonstrate a caring attitude and respect for patients, residents and students; value human dignity; demonstrate a passion and joy for teaching, learning and working with others and participating in community service activities.

Additionally, Dr. Susan Robins was honored with the Faculty of the Year award. Dr. Robins serves as the Site Director for the McLeod Family Medicine Rural Residency Program in Cheraw and cares for patients at McLeod Primary Care Cheraw. Chief Resident Dr. James Johnson presented the award to Dr. Robins. Since my classes arrival three years ago, Dr. Robins has always cared deeply for each individual residents education as well as their personal well-being. She is a shining example of why our residency program is so very fortunate to have the faculty that we do to help guide us to becoming the best possible doctors that we can be, said Dr. Johnson.

Here is the original post:

Residents and Faculty Honored During McLeod Family Medicine Residency Graduation - McLeod Health

Psychedelic Drugs Are Moving From The Fringes Of Medicine To The Mainstream – Forbes

Magic mushroom, computer-enhanced composite image.

Psychedelic agents are experiencing a veritable renaissance. And this time not as illicit mind-expanding drugs that helped give shape to the 1960s counterculture. In recent years a slew of psychedelic agents have filled the drug development pipeline. These therapeutics are being investigated for treating conditions, such as major depressive disorder, severe anxiety, and substance abuse. Psychedelic therapeutics have moved from the fringes of medicine to the mainstream.

In May, the journal Nature Medicine published findings from a study on MDMA - Methylenedioxymethamphetamine - commonly known as Ecstasy or Molly. The first Phase 3 clinical trial conducted with psychedelic-assisted therapy found that MDMA combined with psychological counseling yielded marked relief to patients with severe post-traumatic stress disorder.

In April, a study published in the New England Journal of Medicine highlighted the benefits of treating depression with psilocybin, the psychoactive ingredient in magic mushrooms, have excited scientists, psychotherapists and entrepreneurs in the rapidly expanding field of psychedelic medicine. Other studies suggest substantial rapid and enduring antidepressant effects of psilocybin-assisted therapy among patients with major depressive disorder. The Food and Drug Administration (FDA) granted psilocybin breakthrough therapy designation.

And, esketamine was approved by the FDA on March 5th, 2019, for treatment-resistant depression. It is sold under the trade name, Spravato. Esketamine became the first FDA-approved psychedelic treatment for a psychiatric disorder. In August of last year, the FDA extended its approval for esketamine to adults with major depressive disorder with acute suicidal ideation or behavior.

In a disease area such as mental health, with a significant amount of unmet need, any increase in promising treatment options is welcome. Major depressive disorder affects approximately 17 million Americans, many of whom currently suffer from a lack of adequate treatment alternatives. However, there are possible pitfalls associated with each of the aforementioned drugs where the precautionary principle may apply. In each instance, risks of abuse and diversion must be considered.

There is the potential for abuse and possible long-term negative effects related to MDMA, an amphetamine derivative. Research hasnt definitively answered whether MDMA is addictive, although data suggest that regular MDMA use yields adaptations in the serotonin and dopamine pathways in the brain and central nervous system that may be connected to substance use disorder as well as increased impulsivity. Clearly this is an important factor to consider as medical uses for MDMA are being pursued.

In the case of psilocybin, in the span of a couple of years, the drug has gone from being a completely prohibited Schedule I drug, defined by the Drug Enforcement Administration as a controlled substance having no currently accepted medical use and a high potential for abuse, to a what some researchers recommend should be a Schedule IV controlled substance drug with a relatively low potential for abuse.

Yet, psilocybin is considered to have abuse potential. While advocates assert that psilocybin is not addictive, chronic abuse and misuse can lead to hallucinogen use disorder.

The FDA is the focal point for abuse potential assessment, and works with sponsors of agents with possible abuse potential to determine the studies required to establish approval endpoints, scheduling recommendations, and all aspects of labeling. Psilocybin has not yet been examined in an abuse potential study that would meet the criteria recommended by the FDA in its 2017 Guidance: Assessment of the Abuse Potential of Drugs.

Furthermore, abuse and misuse are not the only problems that require investigating. However rare the risks appear to be from initial reports, possible adverse events must be looked into thoroughly, particularly since clinical trial and real-world settings are vastly different. Persistent use of psilocybin may lead to long-term psychosis, alter a persons personality and perception of reality, and produce hallucinations.

Dr. Bogenschutz, a professor of psychiatry at New York University, said that until now the majority of clinical studies on psilocybin have been conducted with relatively small numbers of individuals in clinical settings designed to exclude those with schizophrenia and other serious mental problems. It is precisely these subgroups that could be predisposed to psychotic episodes, exacerbated by possibly psychosis-inducing psilocybin.

And then theres the case of esketamine, which is the S-enantiomer of ketamine, a similar (in molecular structure) but more potent agent than ketamine.The FDA label for esketamine includes a black box warning of the potential for misuse.

The experience with off-label use of ketamine for clinical depression is a sobering reminder of the importance of close monitoring for the purpose of preventing abuse and misuse from occurring. As noted in several clinical studies, ketamine drug-seeking behavior has appeared as a clinical issue, with some patients shopping infusion clinics to obtain repeated injections for mood elevation. In 2017, the American Psychiatric Association issued a consensus statement on ketamine for mood disorders: Considering the known potential for abuse of ketamine and recent reports of abuse of prescribed ketamine for the treatment of depression, clinicians should be vigilant about assessing the potential for patients to develop ketamine use disorder.

Classified as a Schedule III substance, esketamines safety profile based on real-world data includes possible dissociation, sedation, and suicidal ideation. Mark Horowitz of University College London, asserted that what the sponsor demonstrated very clearly in the trials that theyve done is that esketamine gets you a bit high for a few hours and has little effect on depression scores at 4 weeks. Horowitz maintains that esketamine is an ineffective medication. On top of that, its also a reasonably dangerous medication.

Ignoring or downplaying possible downsides or risk factors isnt going to make these issues go away. The experience with prescription opioids and other drugs, such as benzodiazepines, should give pause. Despite the benzodiazepine clonazepam being the most commonly diverted pharmaceutical in the U.S., it remains the drug most prescribed by psychiatrists to Medicare beneficiaries.

Regulators are proactively establishing a strict set of protocols for psychedelic medications. Several regulatory barriers have already been erected for the approved drug esketamine. Presumably, a similar set of restrictions would be put in place for MDMA and psilocybin. With respect to psilocybin, it appears that only licensed therapists and manufacturers will be allowed to grow the mushrooms or extract psilocybin from them, or to synthetically produce the drug, set up a psilocybin therapy center or provide therapy. Importantly, individuals being treated with the drug may only ingest it at a licensed facility with a certified therapist present.

These safeguards will help, along with systematically implemented post-marketing surveillance plans. Still, regulators and treatment providers will need to work out safe ways of administering these powerful substances in the real world, which will be different from the highly circumscribed and controlled conditions of clinical trials.

See more here:

Psychedelic Drugs Are Moving From The Fringes Of Medicine To The Mainstream - Forbes

Stallergenes Greer and Alyatec Announce Research Collaboration to Advance Precision Medicine in Allergen Immunotherapy – Business Wire

LONDON & STRASBOURG, France--(BUSINESS WIRE)--Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), and Alyatec, a contract research organisation based in Strasbourg University Hospital (France), today announced that they have entered into a collaboration to advance precision medicine in AIT.

With this collaboration, Stallergenes Greer aims to strengthen its precision medicine-based approach and the management of patients with allergies by expanding its knowledge of allergy pathophysiology and endotypes, AIT mode of action and clinical validation.

This research collaboration brings together the longstanding expertise of Stallergenes Greer in AIT and Alyatecs competencies in research and clinical services as well as its state-of-the-art technology, including a new generation environmental exposure chamber.

We are excited about the collaboration with Alyatec which will support Stallergenes Greers ambition to advance the practice of allergology. With Alyatec and its team of distinguished key opinion leaders, Stallergenes Greer will continue to build on precision medicine and personalised healthcare to significantly improve patient disease outcomes, declared Amer Jaber, Executive VP Operations Europe and International and President of Stallergenes SAS.

This collaboration is a remarkable opportunity for Alyatec to develop precision medicine in AIT. The field of allergology is the oldest form of precision medicine as patient phenotypes are directly related to specific results provided by skin tests. We are convinced that adapting immunotherapy to the phenotype of each patient, in other words finding the right immunotherapy for the right patient, is the future of AIT, stated Professor Frdric de Blay, Principal investigator and Medical expert of Alyatec.

ABOUT ALLERGEN IMMUNOTHERAPY

Allergies are the most prevalent and fastest growing chronic disease in the industrialised world, affecting over one billion people worldwide1. Allergen immunotherapy is an allergy treatment designed to alter the natural course of respiratory allergies by treating the underlying cause of the disease. Allergen extracts are modifying disease by inducing tolerance in the immune system2,3.

ABOUT STALLERGENES GREER

Headquartered in London (UK), Stallergenes Greer Ltd is a global healthcare company specialising in the diagnosis and treatment of allergies through the development and commercialisation of allergy immunotherapy products and services. Stallergenes Greer Ltd is the parent company of Greer Laboratories, Inc. (whose registered office is in the United States) and Stallergenes SAS (whose registered office is in France).

ABOUT ALYATEC

Alyatec is a contract research organisation based in Strasbourg University Hospital (France) which performs clinical studies related to respiratory allergies. Thanks to its specific knowledge and medical expertise Alyatec can evaluate the effect of solutions against asthma, rhinitis and conjunctivitis caused by environmental factors such as cat allergens, pollens and house dust mites. To perform these clinical trials, Alyatec has an environmental exposure chamber which enables the assessment of the mode of action of allergy treatment solutions in an innovative and efficient way. The company provides a full range of clinical services in the area of respiratory allergies with all the benefits related to the use of Alyatecs allergen exposure unit.

1.World Health organisation, Ambient Air Pollution: Health Impacts2.Global Atlas of Allergy, EAACI 20143.Halken 2017: EAACI guidelines on allergen immunotherapy: Prevention of allergy

View original post here:

Stallergenes Greer and Alyatec Announce Research Collaboration to Advance Precision Medicine in Allergen Immunotherapy - Business Wire

University Of Maryland School Of Medicine, Medical Center Joint Study Says U.S. Not Ready For Next Pandemic – CBS Baltimore

BALTIMORE (WJZ) As the Covid-19 pandemic wanes in the United States, hospitals nationwide may not be prepared for the next pandemic, according to a new study from the University of Maryland School of Medicine and the University of Maryland Medical Center. The study was published last month in the Journal of Healthcare Management.

The studys lead author, Dr. David Marcozzi, professor of emergency medicine at the school of medicine and the chief clinical officer and hospital senior vice president, and his colleagues developed and published a surge index tool that linked standard reported hospital information to healthcare preparedness elements.

The tool, called the Hospital Medical Surge Preparedness Index (HMSPI), used data from 2005 to 2014 to produce a score designed to predict how well a hospital can handle a sudden influx in patients due to a mass shooting or infectious disease outbreak. Such data included the size of the medical staff, the number of hospital beds, and the amount of equipment and supplies.

Medical surge capacity is an important measure to assess a hospitals ability to expand quickly beyond normal services to meet increased demand for healthcare, according to a statement from the school of medicine.

The Las Vegas mass shooting in 2017, for example, sent more than 500 concertgoers to local hospitals. During the early weeks of the COVID-19 pandemic, New York City hospitals were under siege with 4,000 patients hospitalized. To calculate the HMSPI, researchers input data from four important metrics:

Marcozzi and his colleagues used data from the American Hospital Associations annual surveys of more than 6,200 hospitals nationwide that were collected from 2005 to 2014. They also employed data from the U.S. Census Bureau to determine population estimates in cities and the Dartmouth Atlas Project to establish the geographic service area of each hospital. They combined the hospital metrics gleaned from the AHAs annual surveys with the geographic data to calculate HMSPI composite scores for hospitals in each state.

Their evaluation found varying levels of increases in HMSPI scores from 2005 to 2014 in every state, which could indicate that states are becoming better prepared to handle a medical surge. The scores also indicated that ideal readiness had not yet been achieved in any state before the COVID-19 pandemic.

Read more from the original source:

University Of Maryland School Of Medicine, Medical Center Joint Study Says U.S. Not Ready For Next Pandemic - CBS Baltimore

Married to Medicine’s Dr. Heavenly Answers Your Burning Reunion Show Questions – E! NEWS

E! You have really rallied around Dr. Contessa. What is your hope for her and her marriage going forward?

Dr. Heavenly: I think that I speak for everyone when we say Contessa is one of the most beautiful, educated, most compassionate people that we know. Our hearts go out to her because we just want her to be happy. I know she is all about family and her kids. But like Toya and so many other people said, your kids want to see you happy so at the end of the day, I want my friend to be happy. That's all.

E!: Can we talk a little bit about Lisa Nicole and Kari returning this season?

Dr. Heavenly: I don't give a damn about them so really, no. They did not come to the reunion. There is no reason to talk about them. I can't think of anything about them. They weren't in the reunion so what is there to talk about?

E! Are you happy that Quad is still part of the show after her divorce?

Dr. Heavenly: Absolutely. I say it all the time. I think there is a youthful energy she brings to the show and I love her. We love her. The show would not be the same without her. And I just think that she's so intelligent. She's so well spoken and I missed her the first half, but the second half she came with fire. She should be, if I had anything to do with it, she should be cast in this season, next season and seasons to come.

Follow this link:

Married to Medicine's Dr. Heavenly Answers Your Burning Reunion Show Questions - E! NEWS

National Museum of Health and Medicine in Silver Spring Reopens Today – Source of the Spring

The National Museum of Health and Medicine in Silver Spring has reopened following a pandemic-related closure, officials announced today (July 7).

The museum, established during the Civil War as the Army Medical Museum, strives to preserve, inspire, and inform the history, research, and advancement of military and civilian medicine through world-class collections, digital technology, and public engagement, according to its vision statement.

Its collections include historical and anatomical items, along with historical archives, among other items. The museum also conducts guided group tours and sponsors formal and informal educational programs when fully open.

The museum is reopening to the public under COVID-19 guidelines. Those include a screening questionnaire, temperature checks, mandatory masks for anyone more than 2 years old, and no outside food and drinks, except water, will be permitted.

In addition, access will be limited to no more than 40 people at one time, and visitors will be expected to maintain social distancing.

The museum is open from Wednesday to Sunday, 10 a.m.5:30 p.m., and closed on Monday and Tuesday. It is located at 2500 Linden Lane in Silver Spring.

Photo courtesy National Museum of Health and Medicine

Follow Source of the Spring onFacebook,Instagram,LinkedIn,andTwitter. Send us News Tipshere, sign up for our free Weekly Emailshere, and learn how to Support Our Workhere.

View post:

National Museum of Health and Medicine in Silver Spring Reopens Today - Source of the Spring